Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actelion

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Actelion's 2013 sales performance.

Deal Watch January 2018

In comparison, this time last year January's top 20 deals represented $52bn in aggregate headline value (buoyed by J&J's $30bn acquisition of Actelion).

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ French pharma firm offers $105 apiece for the spin-out’s shares. After missing out on earlier bids for Medivation and Actelion, Sanofi has agreed to buy Biogen haematology spin-out ... Medivation in 2016 and was also trumped by Johnson &Johnson after

After some big setbacks, Sanofi talks up its R&D portfolio

After some big setbacks, Sanofi talks up its R&D portfolio However, it has tried and failed to make two pipeline-boosting acquisitions of late, losing out out to rivals bidding for Actelion and Medivation.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics